The FDA has approved a new use for Eli Lilly's (LLY) lung cancer treatment Alimta, now saying...

|About: Eli Lilly and Company (LLY)|By:, SA News Editor

The FDA has approved a new use for Eli Lilly's (LLY) lung cancer treatment Alimta, now saying that patients may receive the drug as a maintenance therapy following first-line treatment. The FDA cites Phase III data, the first of its kind, that demonstrates better overall survival advantages with continued maintenance. Shares +1% AH.